Dr. Hebbar of CalciMedica Talks Auxora Clinical Trial Targeting COVID-19, CRAC, and More| Podcast S2 E36 Media coverage / By jpolicano
Dozens of Houston’s sickest COVID-19 patients picked for trial of new drug that could reduce need for ventilator by 50 percent Media coverage / By jpolicano
FDA greenlights expansion of COVID-19 study to VCU Medical Center after positive data Media coverage / By jpolicano
VC Daily: Biotech Startups Ramp Up Funding and Fight Against Coronavirus; Companies Face New Privacy Ruling Media coverage / By jpolicano
CalciMedica’s Auxora Shows Promise As COVID-19 Treatment, Patients Recovered Twice As Fast Media coverage / By jpolicano
San Diego biotech’s drug shows early promise in treating COVID-19 pneumonia Media coverage / By jpolicano
A drug for COVID-19 breathing problems, tested in Minnesota, shows promise Media coverage / By jpolicano
Interim analysis indicates Auxora™ is effective in severe COVID-19 pneumonia patients Media coverage / By jpolicano